Arkolith/Insider Trading/SRNE/Form 4

Janda Kim

DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Sep 14, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 13, 2021Sell(S)8K$8.04$64K3K
Sep 13, 2021Option exercise(M)8K$3.50$28K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 13, 2021Option exercise(M)8K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-055954) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML